Remogliflozin Etabonate + Teneligliptin Tablet
Remogliflozin Etabonate + Teneligliptin Tablet
Remogliflozin Etabonate + Teneligliptin — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — SGLT2 inhibitor + DPP-4 inhibitor antidiabetic
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Remogliflozin Etabonate + Teneligliptin Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Type 2 diabetes mellitus, alone or with metformin
- Adjunct to diet and exercise for glycaemic control
- Combination therapy with metformin, sulfonylureas or SGLT2 inhibitors
Mechanism of Action
Remogliflozin Etabonate — A prodrug converted to remogliflozin, which blocks renal SGLT2, reducing glucose reabsorption and increasing glucose excretion in urine to lower blood sugar.
Teneligliptin — Teneligliptin inhibits the enzyme DPP-4, which normally breaks down the incretin hormones GLP-1 and GIP. Higher incretin levels increase glucose-dependent insulin release and reduce glucagon, lowering blood glucose with little hypoglycaemia risk when used alone.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Remogliflozin Etabonate + Teneligliptin Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Genital fungal infections
- Urinary tract infections
- Increased urination
- Low blood sugar with sulfonylureas or insulin
- Constipation or abdominal discomfort
- Headache
Contraindications
- Known hypersensitivity to any component of the formulation
- Type 1 diabetes or diabetic ketoacidosis
- Severe renal impairment
- History of pancreatitis; stop if severe abdominal pain occurs
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Remogliflozin Etabonate + Teneligliptin Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Remogliflozin Etabonate + Teneligliptin. It is a fixed-dose combination of SGLT2 inhibitor and DPP-4 inhibitor antidiabetic, used for type 2 diabetes mellitus, alone or with metformin and combination therapy with metformin, sulfonylureas or SGLT2 inhibitors. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Remogliflozin Etabonate + Teneligliptin Tablet brings together Remogliflozin Etabonate (SGLT2 inhibitor) and Teneligliptin (DPP-4 inhibitor antidiabetic) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Remogliflozin Etabonate + Teneligliptin Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Remogliflozin Etabonate + Teneligliptin Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Remogliflozin Etabonate + Teneligliptin Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Remogliflozin Etabonate + Teneligliptin Tablet used for?
Remogliflozin Etabonate + Teneligliptin Tablet is used for type 2 diabetes mellitus, alone or with metformin; adjunct to diet and exercise for glycaemic control; combination therapy with metformin, sulfonylureas or SGLT2 inhibitors. It should be used as advised by a registered medical practitioner.
Is Remogliflozin Etabonate + Teneligliptin Tablet available for PCD pharma franchise on monopoly basis?
Yes. Remogliflozin Etabonate + Teneligliptin Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Remogliflozin Etabonate + Teneligliptin for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Remogliflozin Etabonate + Teneligliptin Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Remogliflozin Etabonate + Teneligliptin Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Remogliflozin Etabonate + Teneligliptin?
Remogliflozin Etabonate + Teneligliptin is a fixed-dose combination of SGLT2 inhibitor and DPP-4 inhibitor antidiabetic (therapeutic class: Fixed-Dose Combination — SGLT2 inhibitor + DPP-4 inhibitor antidiabetic).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Remogliflozin Etabonate + Teneligliptin Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Remogliflozin Etabonate + Teneligliptin Tablet?